THURSDAY, May 6, 2021 (HealthDay News) — In two real-world studies, Pfizer’s COVID-19 vaccine appears to be standing up well against the challenges posed by more contagious coronavirus variants from Britain and South Africa. The Pfizer mRNA vaccine showed about 90% documented effectiveness in protecting against infection with the BritishContinue Reading

THURSDAY, May 6, 2021 (HealthDay News) — Two doses of the Pfizer-BioNTech COVID-19 vaccine provide a high level of protection for populations, a new study shows. The findings from Israel — the first nation to report national data on the vaccine — show that two doses provide more than 95%Continue Reading

TUESDAY, May 4, 2021 (HealthDay News) — Two widely used COVID-19 vaccines — Pfizer and Moderna — will likely remain powerfully protective against developing serious illness even if coronavirus variants somehow manage to infect vaccinated patients, new research suggests. Both vaccines are based on messenger RNA (mRNA) technology. And investigatorsContinue Reading

FRIDAY, April 30, 2021 (HealthDay News) — Cancer might seem like a modern problem, but new research has revealed that it affected up to 14% of adults in medieval Britain. University of Cambridge researchers used X-rays and CT scans to search for evidence of cancer inside skeletal remains excavated asContinue Reading

FRIDAY, April 30, 2021 (HealthDay News) — COVID-19 research efforts must now shift toward the development of a pill that can prevent serious illness in the recently infected, experts say. “We need a pill that can keep people out of the hospital, and the time to develop that is rightContinue Reading

FRIDAY, April 30, 2021 (HealthDay News) — The HPV vaccine isn’t reaching enough young American men, researchers report. The vaccine protects against reproductive warts as well as cancers caused by human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Many young women get the HPV vaccineContinue Reading